About the S.T.A.B.L.E. Program |
|
xi | |
Program Development |
|
xi | |
Module Content |
|
xi | |
Course Format: Didactic-Interactive or Self-Study |
|
xi | |
Lead Instructor Qualifications |
|
xii | |
Who Should Participate in S.T.A.B.L.E.? |
|
xii | |
How Long Does it Take to Administer the Learner Course? |
|
xiii | |
How to Use the Instructor Manual |
|
xiii | |
Page Numbering |
|
xiii | |
Answers to Practice Sessions |
|
xiii | |
Program Slides and Hyperlinks |
|
xiii | |
Pre- and Post-Testing |
|
xiv | |
Where Can I Find the Tests? |
|
xiv | |
Administering the Pre-Test |
|
xiv | |
The Post-Test |
|
xiv | |
Administering the Post-Test |
|
xiv | |
Equipment Needed for Program Presentation |
|
xiv | |
Using SecurePack Software |
|
xv | |
System Requirements |
|
xv | |
Navigating the Slide Program in SecurePack |
|
xv | |
Troubleshooting Hyperlinks |
|
xv | |
S.T.A.B.L.E. Program Components |
|
xvi | |
How to Order Program Materials |
|
xvi | |
Renewal Course Options |
|
xvii | |
Option One |
|
xvii | |
Option Two |
|
xvii | |
Beginning the S.T.A.B.L.E. Program Lecture Presentation |
|
xviii | |
Frequently Asked Questions |
|
xviii | |
|
|
|
|
1 | (1) |
|
|
1 | (1) |
|
|
1 | (1) |
|
|
1 | (1) |
|
The S.T.A.B.L.E. Mnemonic |
|
|
2 | (1) |
|
|
3 | (2) |
|
|
5 | (38) |
|
Sugar and Safe Care Module Objectives |
|
|
6 | (1) |
|
|
7 | (1) |
|
Sugar --- General Guidelines |
|
|
8 | (1) |
|
Preparation for Extrauterine Life and Factors that Affect Glucose Stability After Birth |
|
|
9 | (5) |
|
Three Main Factors that Impact Blood Glucose After Birth |
|
|
9 | (1) |
|
Inadequate Glycogen Stores: High Risk Groups |
|
|
10 | (2) |
|
Hyperinsulinemia: High Risk Groups |
|
|
12 | (1) |
|
Increased Utilization of Glucose: High Risk Groups |
|
|
13 | (1) |
|
Review: Infants at increased risk for hypoglycemia |
|
|
14 | (1) |
|
|
15 | (1) |
|
Bedside Monitoring of Blood Glucose |
|
|
15 | (1) |
|
|
16 | (1) |
|
Recommended Target Blood Sugar for Sick Infants Who Require Neonatal Intensive Care |
|
|
16 | (1) |
|
Initial IV Fluid and Rate |
|
|
17 | (5) |
|
Indications for Umbilical Catheterization and Safe Use of Umbilical Catheters |
|
|
22 | (6) |
|
|
26 | (2) |
|
Sugar Module -- Key Points |
|
|
28 | (1) |
|
General Approach for the Initial Fluid and Glucose Management of Sick Infants |
|
|
28 | (1) |
|
Appendix 1.1 Hyperlink: Malrotation and Midgut Volvulus |
|
|
29 | (1) |
|
Appendix 1.2 Classification of Newborns (Both Sexes) by Intrauterine Growth and Gestational Age |
|
|
30 | (1) |
|
Appendix 1.3 Hyperlink: IV Insertion |
|
|
31 | (1) |
|
Appendix 1.4 Securing a Peripheral IV Using Clear Surgical Dressing and 1/2-Inch Clear Tape |
|
|
32 | (2) |
|
Appendix 1.5 Calculating Umbilical Catheter Depth Using a Mathematical Formula |
|
|
34 | (1) |
|
Appendix 1.6 Determining Umbilical Catheter Tip Location Using a Graph |
|
|
35 | (1) |
|
Appendix 1.7 Example: How To Use the Shoulder-To-Umbilical-Length Measurement Graph to Calculate Umbilical Artery Catheter Insertion Depth |
|
|
36 | (1) |
|
Appendix 1.8 Hyperlink: Umbilical Line Malpositions |
|
|
37 | (2) |
|
Appendix 1.9 Recommended Actions to Correct the Location of a Malpositioned UAC |
|
|
39 | (1) |
|
Appendix 1.10 Hyperlink: Umbilical Catheterization Procedure |
|
|
40 | (2) |
|
Appendix 1.11 Securing an Umbilical Catheter |
|
|
42 | (1) |
|
|
43 | (20) |
|
Temperature Module Objectives |
|
|
44 | (1) |
|
|
44 | (1) |
|
|
44 | (1) |
|
Review: Infants at Highest Risk for Hypothermia |
|
|
45 | (1) |
|
What is a Normal Core Temperature for Infants and What is Considered Hypothermic? |
|
|
46 | (1) |
|
Normal Response to Cold Stress in Term Infants |
|
|
46 | (3) |
|
|
49 | (6) |
|
|
50 | (1) |
|
|
51 | (1) |
|
|
52 | (1) |
|
|
53 | (1) |
|
|
54 | (1) |
|
Physiologic Response to Hypothermia: Term and Preterm Infants |
|
|
55 | (3) |
|
Norepinephrine and Peripheral Vasoconstriction |
|
|
56 | (1) |
|
Norepinephrine and Pulmonary Vasoconstriction |
|
|
57 | (1) |
|
Detrimetal Effects of Hypothermia |
|
|
58 | (1) |
|
Rewarming the Hypothermic Infant |
|
|
59 | (2) |
|
Incubator Method of Rewarming |
|
|
60 | (1) |
|
Radiant Warmer Method of Rewarming |
|
|
61 | (1) |
|
Temperature Module-- Key Points |
|
|
61 | (2) |
|
|
63 | (66) |
|
|
64 | (1) |
|
Airway --- General Guidelines |
|
|
64 | (1) |
|
Patient Evaluation and Monitoring |
|
|
65 | (1) |
|
Assessment of Respiratory Distress |
|
|
66 | (1) |
|
Degrees of Respiratory Distress |
|
|
66 | (1) |
|
|
67 | (3) |
|
|
68 | (1) |
|
Tachypnea and Increased PCO2 |
|
|
68 | (2) |
|
|
70 | (1) |
|
|
70 | (5) |
|
Transillumination for Pneumothorax Detection |
|
|
71 | (2) |
|
|
73 | (1) |
|
Treatment of a Pneumothorax |
|
|
74 | (1) |
|
Respiratory Distress and Work of Breathing |
|
|
75 | (1) |
|
|
76 | (5) |
|
The Process of Gas Exchange |
|
|
76 | (2) |
|
Tissue Hypoxia and Anaerobic Metabolism |
|
|
78 | (1) |
|
Pre- and Post-ductal Oxygen Saturation Monitoring |
|
|
79 | (2) |
|
|
81 | (1) |
|
Blood Gas Interpretation Using a Modified Acid-Base Alignment Nomogram and S.T.A.B.L.E. Blood Gas Rules |
|
|
82 | (9) |
|
S.T.A.B.L.E. Blood Gas Rules |
|
|
83 | (3) |
|
Causes of Metabolic Acidosis |
|
|
86 | (1) |
|
Treatment of Metabolic Acidosis |
|
|
86 | (1) |
|
Causes of Respiratory Acidosis |
|
|
87 | (1) |
|
Treatment of Respiratory Acidosis |
|
|
87 | (4) |
|
|
91 | (1) |
|
|
92 | (10) |
|
|
92 | (1) |
|
Assisting with Intubation |
|
|
93 | (6) |
|
Location of the Endotracheal Tube on Chest X-ray |
|
|
99 | (1) |
|
Initial Ventilator Support |
|
|
100 | (2) |
|
Practice Session: Blood Gas Interpretation |
|
|
102 | (7) |
|
Pain Control with Analgesics |
|
|
109 | (1) |
|
|
110 | (1) |
|
Appendix 3.1 Needle Aspiration of the Chest and Chest Tube Insertion Procedures |
|
|
111 | (4) |
|
Appendix 3.2 Hyperlink: Respiratory Conditions and Airway Challenges: Congenital Diaphragmatic Hernia, Tracheoesophageal Fistula / Esophageal Atresia, Choanal Atresia, Pierre-Robin Sequence |
|
|
115 | (4) |
|
Appendix 3.3 Hyperlink: Oxygen-Hemoglobin Dissociation Curve |
|
|
119 | (1) |
|
Appendix 3.4 Hyperlink: Persistent Pulmonary Hypertension (PPHN) |
|
|
120 | (4) |
|
Appendix 3.5 Hyperlink: Continuous Positive Airway Pressure (CPAP) |
|
|
124 | (1) |
|
Appendix 3.6 Hyperlink: T-Piece Resuscitator |
|
|
125 | (1) |
|
Appendix 3.7 Hyperlink: Blood Gas Practice Session |
|
|
126 | (1) |
|
Appendix 3.8 Hyperlink: Pain Assessment |
|
|
127 | (2) |
|
|
129 | (26) |
|
Blood Pressure Module Objectives |
|
|
130 | (1) |
|
|
130 | (1) |
|
The Three Types of Shock: Hypovolemic, Cardiogenic, Septic |
|
|
130 | (6) |
|
|
130 | (1) |
|
|
131 | (1) |
|
Septic (distributive) Shock |
|
|
132 | (4) |
|
The Principles of Cardiac Output |
|
|
136 | (1) |
|
Factors that Negatively Affect Heart Function |
|
|
136 | (1) |
|
|
136 | (4) |
|
Treatment of Hypovolemic (low blood volume) Shock |
|
|
138 | (2) |
|
Treatment of Cardiogenic (heart failure) Shock |
|
|
140 | (1) |
|
Treatment of Septic (distributive) Shock |
|
|
140 | (1) |
|
Medications Used to Treat Cardiogenic and Septic Shock |
|
|
140 | (2) |
|
|
140 | (1) |
|
Sodium Bicarbonate 4.2% solution |
|
|
140 | (1) |
|
|
141 | (1) |
|
Dopamine Dosing for Newborns and How to Calculate a Final Standardized Concentration of 800 Micrograms per ml IV Fluid |
|
|
142 | (3) |
|
Rules for Dopamine Infusion |
|
|
144 | (1) |
|
Practice Session: Dopamine rate |
|
|
145 | (2) |
|
Appendix 4.1 Hyperlink: Evaluation of Scalp Swelling |
|
|
147 | (2) |
|
Appendix 4.2 Hyperlink: Case Study: Baby Doe and It Isn't Just the Lungs: A Case Presentation |
|
|
149 | (6) |
|
|
155 | (24) |
|
Lab Work Module Objectives |
|
|
156 | (1) |
|
Lab work - General Guidelines |
|
|
156 | (2) |
|
|
158 | (1) |
|
|
158 | (1) |
|
|
158 | (1) |
|
|
159 | (1) |
|
|
159 | (1) |
|
Complete Blood Count (CBC) Interpretation |
|
|
159 | (7) |
|
|
160 | (1) |
|
The Absolute Neutrophil Count (ANC) |
|
|
161 | (3) |
|
The Immature to Total (I/T) Ratio |
|
|
164 | (1) |
|
Platelet Count: Normal Values in Young Infants |
|
|
165 | (1) |
|
Initial Antibiotic Therapy for Sick Newborns |
|
|
166 | (2) |
|
Preparing for Administration of Antibiotics |
|
|
166 | (1) |
|
Antibiotics and Doses -- Ampicillin and Gentamicin |
|
|
166 | (2) |
|
Lab Work Module -- Key Points |
|
|
168 | (1) |
|
Practice Session: Lab Work |
|
|
168 | (5) |
|
Appendix 5.1 Group B Streptococcal Infection |
|
|
173 | (1) |
|
Appendix 5.2 Prevention of Perinatal Group B Strepfococcal Disease |
|
|
174 | (1) |
|
Appendix 5.3 Indications for intrapartum antibiotic prophylaxis to prevent perinatal GBS disease under a universal prenatal screening strategy based on combined vaginal and rectal cultures collected at 35--37 weeks' gestation from all pregnant women |
|
|
175 | (1) |
|
Appendix 5.4 Sample algorithm for GBS prophylaxis for women with threatened preterm delivery |
|
|
176 | (1) |
|
Appendix 5.5 Sample algorithm for the management of a newborn whose mother received intrapartum antibiotics for the prevention of early-onset group B streptococcal disease or suspected chorioamnionitis |
|
|
177 | (1) |
|
Appendix 5.6 Hyperlink: Updated GBS Guidelines CDC 2002 |
|
|
178 | (1) |
|
|
179 | (10) |
|
Emotional Support Module Objectives |
|
|
180 | (1) |
|
|
180 | (1) |
|
Helpful Ideas for when the Infant Requires Transport |
|
|
181 | (6) |
|
Initial Stabilization Period |
|
|
181 | (1) |
|
When the Transport Team Arrives |
|
|
182 | (2) |
|
Care of the Family after Transport of the Infant |
|
|
184 | (3) |
|
Appendix 6.1 Providing Relationship-Based Care to Babies and Their Parents |
|
|
187 | (2) |
|
|
189 | (16) |
|
Quality Improvement Module Objectives |
|
|
190 | (1) |
|
|
190 | (1) |
|
Quality Improvement Evaluation |
|
|
190 | (3) |
|
|
193 | (2) |
|
Appendix 7.1 Application of Error Types to Baby Doe Case Study |
|
|
195 | (2) |
|
Appendix 7.2 Case Study 2 |
|
|
197 | (4) |
|
Appendix 7.3 Pre-transport Stabilization Self-Assessment Tool |
|
|
201 | (4) |
References |
|
205 | |